Dermal and transdermal drug design

International Journal of Pharmaceutical Medicine

Volumn 13, Issue 3, 1999, Pages 155-158

  Hadgraft, J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Design; Drug; Topical; Transdermal

Indexed keywords

CROMOGLYCATE DISODIUM; GLYCERYL TRINITRATE; NEXACT 88; NICOTINE; PENETRATION ENHANCING AGENT; PRODRUG; SKIN LIPID; UNCLASSIFIED DRUG;

ANGINA PECTORIS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; HYDROGEN BOND; LIPID BILAYER; LIPOPHILICITY; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SHORT SURVEY; SKIN PENETRATION; SMOKING CESSATION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032776498     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. 1. Feldmann RJ, Maibach HI. Regional variation in percutaneous absorption of 14C Cortisol in man. J Invest Derm 1967; 48:181-183.
2. 2. Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Derm 1991; 96:495-499.
3. 3. Downing DT, Stewart ME, Wertz PW, Colton SW, Strauss JS. Skin lipids. Comp Biochem Physiol B 1983; 76:673-678.
4. 4. Azimi NA, Spencer IS, Potts RO, Lyttle FE, Chen DA. Fluorescence spectroscopic evaluation of the fluidity gradient in stratum corneum lipids. J Invest Derm 1992; 98:641.
5. 5. Liron Z, Cohen S. Percutaneous absorption of alkanoic acids. 2. Application of regular solution theory. J Pharm Sci 1984; 73:538-542.
6. 6. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992; 9:663-669.
7. 7. Valvani SC, Yalkowsky SH, Roseman TJ. Solubility and partitioning. 4. Aqueous solubility and octanol-water partition coefficients of liquid non-electrolytes. J Pharm Sci 1981; 70:502-507.
8. 8. Degim T, Hadgraft J, Pugh WJ. Modelling the transdermal delivery of non-steroidal anti-inflammatory agents. Proc Internat Symp Control Rel Bioactive Mater 1995; 22:652-653.
9. 9. Roberts MS, Pugh WJ, Hadgraft J. Epidermal permeability - penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int J Pharm 1996; 132:23-32.
10. 10. Pugh WJ, Roberts MS, Hadgraft J. Epidermal permeability - penetrant structure relationships. 3. The effect of hydrogen-bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm 1996; 138:149-165.
11. 11. Nolen HW, Catz P, Friend DR. Percutaneous penetration of methyl phosphonate antisense oligonucleotides. Int J Pharm 1994; 107:169-177.
12. 12. Amsden BG, Goosen MFA. Transdermal delivery of peptide and protein drugs - an overview. AlChE J 1995; 41:1972-1997.
13. 13. Alexander MY, Akhurst RJ. Liposome mediated gene transfer and expression via the skin. Human Mol Genet 1995; 4:2279-2285.
14. 14. Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochem Biophys Acta-Biomemb 1998; 1368:201-215.
15. 15. Hadgraft J, Peck J, Williams DG, Pugh WJ, Allan G. Mechanisms of action of skin penetration enhancers retarders - azone and analogs. Int J Pharm 1996; 141:17-25.
16. 16. Martin RJ, Denyer SP, Hadgraft J. Skin metabolism of topically applied compounds. Int J Pharm 1987; 39:23-32.
17. 17. Bodor N, Zupan J, Selk S. Improved delivery through biological membranes. 7. Dermal delivery of cromoglycic acid (Cromolyn) via its prodrugs. Int J Pharm 1980; 7:63-75.
18. 18. Hadgraft J, Wotton PK, Walters KA. Enhanced transport of anionic chromone drug molecules across artificial lipid membranes by an ion pair mechanism. J Pharm Pharmacol 1985; 37:7P.